BioAdvance Ventures is an innovative venture fund formed in September 2004 to invest in seed and early stage life science companies, located primarily in Southeastern Pennsylvania. The fund is sponsored by BioAdvance and is managed by Quaker BioVentures Inc., (www.quakerbio.com). Click Here to download BioAdvance Ventures press release.

The Fund’s goal is to provide an attractive return to its partners, while stimulating the development and commercialization of emerging life science companies. It is now fully invested in 12 emerging life sciences companies.

Southeastern Pennsylvania ranks among the top regions in the United States in the quality and quantity of life science research as measured by NIH funding to institutions located in the region. This region is home to four medical schools, two schools of pharmacy, and 20 academic and non-profit institutions that conduct medical research, making it an ideal location for early stage venture opportunities.

In addition to its life sciences talent pool, the region is home to a significant concentration of large biopharmaceutical companies. These resources will provide scientific, clinical development and management talent for emerging biopharmaceutical companies.

Address: BioAdvance Ventures
c/o Quaker BioVentures
1811 Chestnut Street
Philadelphia PA 19103
Phone: (215) 988-6800
Fax: (215) 717-2270
Website: www.bioadvanceventures.com